Doximity Reports Fiscal Q1 2025 Financial Results

authorIntellectia.AI1970-01-01
7
DOCS.N
Illustration by Intellectia.AI

Doximity Reports Fiscal Q1 2025 Financial Results

Doximity, Inc. (NYSE:DOCS), the foremost digital platform for U.S. medical professionals, announced its fiscal 2025 first-quarter financial results for the period ending June 30, 2024.

Key Financial Metrics

Metric Q1 2025 (Jun 30, 2024) Q4 2024 YoY Growth Consensus Estimate Comparison to Estimate
Total Revenue $126.7 million $108.5M 17% $119.92 million Above by $6.78 million
Net Income $41.4 million $28.4M 46% Not provided -
Adjusted EBITDA $65.9 million $46.6M 42% Not provided -
Diluted Net Income per Share $0.21 $0.13 61.5% $0.22 Below by $0.01
Non-GAAP Diluted Net Income per Share $0.28 $0.19 47.4% Not provided -

Doximity has demonstrated robust financial performance in fiscal Q1 2025, surpassing revenue expectations and exhibiting strong year-over-year growth in both net income and adjusted EBITDA. Though slightly missing the consensus EPS estimate by $0.01, the company still saw a significant increase in profitability.

Revenue Performance Across Major Segments

Segment Q1 2025 Revenue Previous Guidance Comparison to Guidance
Total $126.7 million $119.92 million Above by $6.78 million

The company's revenues outpaced its previous guidance, indicating strong market performance and demand for its digital tools for medical professionals.

Comments from Company Officers

Jeff Tangney, co-founder and CEO of Doximity, highlighted the company's exceptional engagement and profitability, stating, "Last quarter, a record 590,000 unique providers used our AI, telehealth, messaging, and scheduling workflow tools to save time and better serve their patients."

Dividends or Share Repurchase Program

The earnings release did not mention any announcements regarding dividends or a share repurchase program.

Forward Guidance

For the fiscal second quarter ending September 30, 2024, Doximity provided the following guidance: - Revenue: Between $126.5 million and $127.5 million. - Adjusted EBITDA: Between $62.5 million and $63.5 million.

For the fiscal year ending March 31, 2025, the Company provided: - Revenue: Between $514 million and $523 million. - Adjusted EBITDA: Between $248.5 million and $257.5 million.

Stock Price Movement

Post-earnings release, Doximity's stock price experienced a significant increase, with an after-event change of 19.1%.

This concise summary encompasses the financial performance, key metrics, segmental revenue, and forward-looking guidance based on Doximity Inc.'s fiscal Q1 2025 earnings report.

Share